JB Meigs, MA Mittleman, DM Nathan, GH … - Jama, 2000 - Am Med Assoc Context Increased risk for cardiovascular disease in persons with glucose
intolerance (impaired glucose tolerance and type 2 diabetes mellitus) is not
fully explained by concomitant elevations in traditional atherosclerosis ... Cited by 420 - Related articles - BL Direct - All 4 versions
- ►ahajournals.org AR Collins, WP Meehan, U Kintscher, S … - Arteriosclerosis, thrombosis, and vascular biology, 2001 - Am Heart Assoc Abstract—Peroxisome proliferator–activated receptor- (PPAR ) is a
ligand-activated nuclear receptor expressed in all of the major cell types found
in atherosclerotic lesions: monocytes/macrophages, endothelial cells, and ... Cited by 330 - Related articles - BL Direct - All 7 versions
- ►diabetesjournals.org JB Meigs, PF Jacques, J Selhub, DE Singer, … - Diabetes Care, 2001 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—We measured clinical characteristics, plasma
levels of fasting homocysteine, folate, B vitamins, creatinine, and fasting and
2-h insulin and glucose levels after a 75-g oral glucose tolerance test in ... Cited by 171 - Related articles - BL Direct - All 8 versions
PW Wahl, PJ Savage, BM Psaty, TJ Orchard, … - The Lancet, 1998 - Elsevier In the 1989 cohort, the prevalence of untreated diabetes with ADA diagnostic
fasting criteria was 7·7% versus a prevalence of 14·8% by the WHO criteria. In
the African-American cohort, the prevalence of untreated diabetes was 2·7% ... Cited by 160 - Related articles - BL Direct - All 5 versions
- ►ahajournals.org WA Hsueh, RE Law - Arteriosclerosis, thrombosis, and vascular biology, 2001 - Am Heart Assoc Atherosclerosis is a major vascular complication of diabetes and the primary
cause of mortality in persons with this disease. Metabolic abnormalities related
to the Insulin Resistance Syndrome or Metabolic Syndrome may importantly ... Cited by 147 - Related articles - BL Direct - All 9 versions
ES Huang, JB Meigs, DE Singer - The American journal of medicine, 2001 - Elsevier Seven serum cholesterol-lowering trials, six blood pressure–lowering trials,
and five blood glucose-lowering trials met eligibility criteria. For aggregate
cardiac events (coronary heart disease death and nonfatal myocardial ... Cited by 140 - Related articles - BL Direct - All 12 versions
- ►diabetesjournals.org [PDF] M Buysschaert, AS Dramais, PE Wallemacq, … - Diabetes Care, 2000 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS — A total of 122 consecutive type 2 diabetic in-
and outpa- tient subjects (40 men and 82 women) par- ticipated in the study.
Their age and diabetes duration (mean ± 1 SD) were 63 ± 10 and 14 ± 9 ... Cited by 118 - Related articles - BL Direct - All 9 versions
- ►oxfordjournals.org [PDF] N Suskin, RS McKelvie, RJ Burns, R Latini, D … - European heart journal, 2000 - Eur Soc Cardiology Page 1. European Heart Journal (2000) 21, 1368–1375 doi:10.1053/euhj.1999.2043,
available online at http://www.idealibrary.com on ... Cited by 112 - Related articles - BL Direct - All 3 versions
JB Meigs, DE Singer, LM Sullivan, KA Dukes, … - The American journal of medicine, 1997 - Elsevier RESULTS: The mean age of participants was 63 years (range 31 to 91); 51% were
women. The mean duration of NIDDM was 9 years (range <1 to 50), 35% took
insulin, and 48% took sulfonylureas. Mean glycohemoglobin was 10.6%. Sixty ... Cited by 108 - Related articles - BL Direct - All 7 versions
